NeoImmuneTech, Inc.
NeoImmuneTech, Inc.
Share · KR8840140006 (XKOS)
Overview
No Price
Closing Price XKOS 28.01.2026: 746,00 KRW
28.01.2026 06:30
Current Prices from NeoImmuneTech, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
950220.KQ
KRW
28.01.2026 06:30
746,00 KRW
7,00 KRW
+0,95 %
Company Profile for NeoImmuneTech, Inc. Share
NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.
AI Analysis of NeoImmuneTech, Inc.
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of NeoImmuneTech, Inc.
No AI threads available for this company yet.

Company Data

Name NeoImmuneTech, Inc.
Company NeoImmuneTech, Inc.
Website https://www.neoimmunetech.com
Primary Exchange XKOS KOSDAQ
ISIN KR8840140006
Asset Class Share
CEO Luke Yun Suk Oh
Market Capitalization 16 Mrd.
Country United States of America
Currency KRW
Employees 0,1 T
Address 2400 Research Blvd., 20850 Rockville
IPO Date 2021-03-16

Ticker Symbols

Name Symbol
KOSDAQ 950220.KQ
More Shares
Investors who hold NeoImmuneTech, Inc. also have the following shares in their portfolio:
HANESBRANDS INC
HANESBRANDS INC Share
MANITOBA 2027
MANITOBA 2027 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026